Amedeo Smart

Free Medical Literature Service

 

Amedeo

Colorectal Neoplasms
  Free Subscription

Articles published in
Cancer Lett
    April 2024
  1. YANG Y, Qi J, Hu J, Zhou Y, et al
    Lovastatin/SN38 co-loaded liposomes amplified ICB therapeutic effect via remodeling the immunologically-cold colon tumor and synergized stimulation of cGAS-STING pathway.
    Cancer Lett. 2024;588:216765.
    >> Share

  2. ZHOU X, Zhang K, Wang C, Teng Y, et al
    Isthmin-1 promotes growth and progression of colorectal cancer through the interaction with EGFR and YBX-1.
    Cancer Lett. 2024 Apr 7:216868. doi: 10.1016/j.canlet.2024.216868.
    >> Share

  3. JIANG C, Zhou Q, Yi K, Yuan Y, et al
    Colorectal cancer initiation: Understanding early-stage disease for intervention.
    Cancer Lett. 2024 Apr 2:216831. doi: 10.1016/j.canlet.2024.216831.
    >> Share

    March 2024
  4. ZHOU Y, Li H, Zhang Y, Zhao E, et al
    Deubiquitinase USP4 suppresses antitumor immunity by inhibiting IRF3 activation and tumor cell-intrinsic interferon response in colorectal cancer.
    Cancer Lett. 2024 Mar 29:216836. doi: 10.1016/j.canlet.2024.216836.
    >> Share

  5. LIN J, Zhong W, Lyu Z, Peng J, et al
    Circular RNA circTATDN3 promotes the Warburg effect and proliferation in colorectal cancer.
    Cancer Lett. 2024 Mar 26:216825. doi: 10.1016/j.canlet.2024.216825.
    >> Share

  6. ZHANG D, Xie J, Sun F, Xu R, et al
    Pharmacological suppression of HHLA2 glycosylation restores anti-tumor immunity in colorectal cancer.
    Cancer Lett. 2024 Mar 22:216819. doi: 10.1016/j.canlet.2024.216819.
    >> Share

  7. HISANO K, Mizuuchi Y, Ohuchida K, Kawata J, et al
    Microenvironmental changes in familial adenomatous polyposis during colorectal cancer carcinogenesis.
    Cancer Lett. 2024;589:216822.
    >> Share

  8. ZHU Z, Li M, Weng J, Li S, et al
    LncRNA GAS6-AS1 contributes to 5-fluorouracil resistance in colorectal cancer by facilitating the binding of PCBP1 with MCM3.
    Cancer Lett. 2024 Mar 21:216828. doi: 10.1016/j.canlet.2024.216828.
    >> Share

  9. TANG Y, Wei J, Ge X, Yu C, et al
    Intratumoral injection of interferon gamma promotes the efficacy anti-PD1 treatment in colorectal cancer.
    Cancer Lett. 2024 Mar 9:216798. doi: 10.1016/j.canlet.2024.216798.
    >> Share

  10. CHEN Q, Deng Y, Li Y, Chen J, et al
    Association of preoperative aspartate aminotransferase to platelet ratio index with outcomes and tumour microenvironment among colorectal cancer with liver metastases.
    Cancer Lett. 2024 Mar 6:216778. doi: 10.1016/j.canlet.2024.216778.
    >> Share

    February 2024
  11. TAN R, Zhang Z, Ding P, Liu Y, et al
    A growth factor-reduced culture system for colorectal cancer organoids.
    Cancer Lett. 2024 Feb 19:216737. doi: 10.1016/j.canlet.2024.216737.
    >> Share

  12. POTHURAJU R, Khan I, Jain M, Bouvet M, et al
    Colorectal cancer murine models: Initiation to metastasis.
    Cancer Lett. 2024 Feb 13:216704. doi: 10.1016/j.canlet.2024.216704.
    >> Share

  13. XU B, Jia Q, Liao X, Fan T, et al
    Inositol hexaphosphate enhances chemotherapy by reversing senescence induced by persistently activated PERK and diphthamide modification of eEF2.
    Cancer Lett. 2024;582:216591.
    >> Share

    January 2024
  14. ZHU J, Li J, Yang K, Chen Y, et al
    NR4A1 depletion inhibits colorectal cancer progression by promoting necroptosis via the RIG-I-like receptor pathway.
    Cancer Lett. 2024 Jan 30:216693. doi: 10.1016/j.canlet.2024.216693.
    >> Share

  15. TANG J, Lam GT, Brooks RD, Miles M, et al
    Exploring the role of sporadic BRAF and KRAS mutations during colorectal cancer pathogenesis: A spotlight on the contribution of the endosome-lysosome system.
    Cancer Lett. 2024 Jan 28:216639. doi: 10.1016/j.canlet.2024.216639.
    >> Share

  16. WEN X, Qin J, Zhang X, Ye L, et al
    MEK-mediated CHPF2 phosphorylation promotes colorectal cancer cell proliferation and metastasis by activating NF-kappaB signaling.
    Cancer Lett. 2024 Jan 21:216644. doi: 10.1016/j.canlet.2024.216644.
    >> Share

  17. JI L, Fu G, Huang M, Kao X, et al
    scRNA-seq of colorectal cancer shows regional immune atlas with the function of CD20(+) B cells.
    Cancer Lett. 2024 Jan 20:216664. doi: 10.1016/j.canlet.2024.216664.
    >> Share

  18. LIU C, Cheng X, Han K, Hong L, et al
    A novel molecular subtyping based on multi-omics analysis for prognosis predicting in colorectal melanoma: A 16-year prospective multicentric study.
    Cancer Lett. 2024 Jan 19:216663. doi: 10.1016/j.canlet.2024.216663.
    >> Share

  19. MORINO S, Mashima T, Shirai F, Nagayama S, et al
    BET protein-dependent E2F pathway activity confers bell-shaped type resistance to tankyrase inhibitors in APC-mutated colorectal cancer.
    Cancer Lett. 2024 Jan 10:216632. doi: 10.1016/j.canlet.2024.216632.
    >> Share

    December 2023
  20. JIANG X, Yang L, Chen G, Feng X, et al
    Discovery of Kinetin in inhibiting colorectal cancer progression via enhancing PSMB1-mediated RAB34 degradation.
    Cancer Lett. 2023 Dec 28:216600. doi: 10.1016/j.canlet.2023.216600.
    >> Share

  21. DAI X, Chen W, Qiao Y, Chen X, et al
    Dihydroartemisinin inhibits the development of colorectal cancer by GSK-3beta/TCF7/MMP9 pathway and synergies with capecitabine.
    Cancer Lett. 2023 Dec 13:216596. doi: 10.1016/j.canlet.2023.216596.
    >> Share

    November 2023
  22. MA J, Liu Y, Yuan J, Ma Y, et al
    Bcl-xL mediates interferon-beta secretion by protease-activated receptor 2 deficiency through the mitochondrial permeability transition pore in colorectal cancer metastasis.
    Cancer Lett. 2023 Nov 14:216483. doi: 10.1016/j.canlet.2023.216483.
    >> Share

  23. PRIMEAUX M, Liu X, Gowrikumar S, Fatima I, et al
    Claudin-1 interacts with EPHA2 to promote cancer stemness and chemoresistance in colorectal cancer.
    Cancer Lett. 2023;579:216479.
    >> Share

    October 2023
  24. HONG WF, Zhu DX, Chen YJ, Shen XZ, et al
    Coiled-coil domain-containing 154 promotes colorectal cancer proliferation and metastasis via interacting with Minichromosome maintenance complex component 2.
    Cancer Lett. 2023 Oct 18:216460. doi: 10.1016/j.canlet.2023.216460.
    >> Share

  25. YANG J, Liao Y, Wang B, Cui L, et al
    EDARADD promotes colon cancer progression by suppressing E3 ligase Trim21-mediated ubiquitination and degradation of Snail.
    Cancer Lett. 2023;577:216427.
    >> Share

  26. GOU H, Wong CC, Chen H, Shang H, et al
    TRIP6 disrupts tight junctions to promote metastasis and drug resistance and is a therapeutic target in colorectal cancer.
    Cancer Lett. 2023 Oct 10:216438. doi: 10.1016/j.canlet.2023.216438.
    >> Share

  27. ZHOU X, Fu D, Yang H, Le C, et al
    Rigosertib promotes anti-tumor immunity via autophagic degradation of PD-L1 in colorectal cancer cells.
    Cancer Lett. 2023 Oct 5:216422. doi: 10.1016/j.canlet.2023.216422.
    >> Share

    September 2023
  28. CHEN L, Sun K, Qin W, Huang B, et al
    LIMK1 m(6)A-RNA methylation recognized by YTHDC2 induces 5-FU chemoresistance in colorectal cancer via endoplasmic reticulum stress and stress granule formation.
    Cancer Lett. 2023 Sep 29:216420. doi: 10.1016/j.canlet.2023.216420.
    >> Share

  29. MORRIS MT, Jain A, Sun B, Kurbatov V, et al
    Multi-omic analysis reveals metabolic pathways that characterize right-sided colon cancer liver metastasis.
    Cancer Lett. 2023 Sep 14:216384. doi: 10.1016/j.canlet.2023.216384.
    >> Share

    August 2023
  30. ZHUO FF, Li L, Liu TT, Liang XM, et al
    Lycorine promotes IDH1 acetylation to induce mitochondrial dynamics imbalance in colorectal cancer cells.
    Cancer Lett. 2023 Aug 28:216364. doi: 10.1016/j.canlet.2023.216364.
    >> Share

    July 2023
  31. PAN G, Zhang K, Geng S, Lan C, et al
    Corrigendum to "PHF14 knockdown causes apoptosis by inducing DNA damage and impairing the activity of the damage response complex in colorectal cancer" [Cancer Lett. 531 (2022) 109-123].
    Cancer Lett. 2023 Jul 10:216290. doi: 10.1016/j.canlet.2023.216290.
    >> Share

  32. TER STEEGE EJ, Doornbos LW, Haughton PD, van Diest PJ, et al
    R-spondin-3 promotes proliferation and invasion of breast cancer cells independently of Wnt signaling.
    Cancer Lett. 2023 Jul 3:216301. doi: 10.1016/j.canlet.2023.216301.
    >> Share

    June 2023
  33. YAN W, Qiu L, Yang M, Xu A, et al
    CXCL10 mediates CD8(+) T cells to facilitate vessel normalization and improve the efficacy of cetuximab combined with PD-1 checkpoint inhibitors in colorectal cancer.
    Cancer Lett. 2023;567:216263.
    >> Share

  34. HONDO N, Kitazawa M, Koyama M, Nakamura S, et al
    MEK inhibitor and anti-EGFR antibody overcome sotorasib resistance signals and enhance its antitumor effect in colorectal cancer cells.
    Cancer Lett. 2023;567:216264.
    >> Share

  35. RIGILLO G, Belluti S, Campani V, Ragazzini G, et al
    The NF-Y splicing signature controls hybrid EMT and ECM-related pathways to promote aggressiveness of colon cancer.
    Cancer Lett. 2023 Jun 10:216262. doi: 10.1016/j.canlet.2023.216262.
    >> Share

    May 2023
  36. XU K, Yin X, Zhou B, Zheng X, et al
    FOSL2 promotes intertumoral infiltration of T cells and increases pathological complete response rates in locally advanced rectal cancer patients.
    Cancer Lett. 2023;562:216145.
    >> Share

  37. LONG Y, Wang Y, Qu M, Zhang D, et al
    Combined inhibition of EZH2 and the autotaxin-LPA-LPA2 axis exerts synergistic antitumor effects on colon cancer cells.
    Cancer Lett. 2023 May 23:216226. doi: 10.1016/j.canlet.2023.216226.
    >> Share

  38. SHARMA A, Kumar R, Yadav G, Garg P, et al
    Artificial intelligence in intestinal polyp and colorectal cancer prediction.
    Cancer Lett. 2023;565:216238.
    >> Share

  39. HONG JH, Woo IS
    Metronomic chemotherapy as a potential partner of immune checkpoint inhibitors for metastatic colorectal cancer treatment.
    Cancer Lett. 2023;565:216236.
    >> Share

    March 2023
  40. CONI S, Bordone R, Ivy DM, Yurtsever ZN, et al
    Combined inhibition of polyamine metabolism and eIF5A hypusination suppresses colorectal cancer growth through a converging effect on MYC translation.
    Cancer Lett. 2023 Mar 7:216120. doi: 10.1016/j.canlet.2023.216120.
    >> Share

  41. MORIMOTO Y, Yamashita N, Hirose H, Fushimi A, et al
    MUC1-C is necessary for SHP2 activation and BRAF inhibitor resistance in BRAF(V600E) mutant colorectal cancer.
    Cancer Lett. 2023;559:216116.
    >> Share

    February 2023
  42. ONCLERCQ-DELIC R, Buhagiar-Labarchede G, Leboucher S, Larcher T, et al
    Cytidine deaminase deficiency in mice enhances genetic instability but limits the number of chemically induced colon tumors.
    Cancer Lett. 2023;555:216030.
    >> Share

  43. TAN X, Zhang Z, Yao H, Shen L, et al
    Retraction notice to "Tim-4 promotes the growth of colorectal cancer by activating angiogenesis and recruiting tumor-associated macrophages via the PI3K/AKT/mTOR signaling pathway" [Canc. Lett. 436 (2018) 119-128].
    Cancer Lett. 2023 Feb 21:216060. doi: 10.1016/j.canlet.2023.216060.
    >> Share

    December 2022
  44. ZHENG Z, Hou X, Bian Z, Jia W, et al
    Gut microbiota and colorectal cancer metastasis.
    Cancer Lett. 2022;555:216039.
    >> Share

    November 2022
  45. WANG SY, Zhang LJ, Chen GJ, Ni QQ, et al
    COPA A-to-I RNA editing hijacks endoplasmic reticulum stress to promote metastasis in colorectal cancer.
    Cancer Lett. 2022;553:215995.
    >> Share

    September 2022
  46. DENG Y, Gao J, Xu G, Yao Y, et al
    HDAC6-dependent deacetylation of AKAP12 dictates its ubiquitination and promotes colon cancer metastasis.
    Cancer Lett. 2022 Sep 16:215911. doi: 10.1016/j.canlet.2022.215911.
    >> Share

  47. SHEN D, Luo J, Chen L, Ma W, et al
    PARPi treatment enhances radiotherapy-induced ferroptosis and antitumor immune responses via the cGAS signaling pathway in colorectal cancer.
    Cancer Lett. 2022 Sep 15:215919. doi: 10.1016/j.canlet.2022.215919.
    >> Share

  48. TSAI HY, Bronner MP, March JK, Valentine JF, et al
    Metabolic targeting of NRF2 potentiates the efficacy of the TRAP1 inhibitor G-TPP through reduction of ROS detoxification in colorectal cancer.
    Cancer Lett. 2022 Sep 13:215915. doi: 10.1016/j.canlet.2022.215915.
    >> Share

  49. SHIMIZU Y, Maruyama K, Suzuki M, Kawachi H, et al
    Acquired resistance to BRAF inhibitors is mediated by BRAF splicing variants in BRAF V600E mutation-positive colorectal neuroendocrine carcinoma.
    Cancer Lett. 2022;543:215799.
    >> Share

  50. CHEN TW, Hung WZ, Chiang SF, Chen WT, et al
    Dual inhibition of TGFbeta signaling and CSF1/CSF1R reprograms tumor-infiltrating macrophages and improves response to chemotherapy via suppressing PD-L1.
    Cancer Lett. 2022;543:215795.
    >> Share

  51. SONG CH, Kim N, Nam RH, Choi SI, et al
    Combination treatment with 17beta-estradiol and anti-PD-L1 suppresses MC38 tumor growth by reducing PD-L1 expression and enhancing M1 macrophage population in MC38 colon tumor model.
    Cancer Lett. 2022;543:215780.
    >> Share

    August 2022
  52. WALTERSKIRCHEN N, Muller C, Ramos C, Zeindl S, et al
    Metastatic colorectal carcinoma-associated fibroblasts have immunosuppressive properties related to increased IGFBP2 expression.
    Cancer Lett. 2022;540:215737.
    >> Share

    July 2022
  53. ZHAO W, Jin L, Chen P, Li D, et al
    Colorectal cancer immunotherapy-Recent progress and future directions.
    Cancer Lett. 2022 Jul 7:215816. doi: 10.1016/j.canlet.2022.215816.
    >> Share

    June 2022
  54. ALVES JM, Prado-Lopez S, Tomas L, Valecha M, et al
    Clonality and timing of relapsing colorectal cancer metastasis revealed through whole-genome single-cell sequencing.
    Cancer Lett. 2022;543:215767.
    >> Share

    May 2022
  55. CHENG Q, Zheng H, Li M, Wang H, et al
    LGR4 cooperates with PrPc to endow the stemness of colorectal cancer stem cells contributing to tumorigenesis and liver metastasis.
    Cancer Lett. 2022;540:215725.
    >> Share

  56. WANG Q, Jiang D, Ye Q, Zhou W, et al
    A widely expressed free immunoglobulin kappa chain with a unique Vkappa4-1/Jkappa3 pattern promotes colon cancer invasion and metastasis by activating the integrin beta1/FAK pathway.
    Cancer Lett. 2022 May 6:215720. doi: 10.1016/j.canlet.2022.215720.
    >> Share

    April 2022
  57. YAMADA H, Takeshima H, Fujiki R, Yamashita S, et al
    ARID1A loss-of-function induces CpG island methylator phenotype.
    Cancer Lett. 2022;532:215587.
    >> Share

    March 2022
  58. TANG K, Wu Z, Sun M, Huang X, et al
    Elevated MMP10/13 mediated barrier disruption and NF-kappaB activation aggravate colitis and colon tumorigenesis in both individual or full miR-148/152 family knockout mice.
    Cancer Lett. 2022;529:53-69.
    >> Share

  59. DUAN JJ, Wang D, Cai J, Chen JJ, et al
    An aldehyde dehydrogenase 1A3 inhibitor attenuates the metastasis of human colorectal cancer.
    Cancer Lett. 2022 Mar 21:215662. doi: 10.1016/j.canlet.2022.215662.
    >> Share

  60. SHEN Z, Li Z, Liu Y, Li Y, et al
    GLUT5-KHK axis-mediated fructose metabolism drives proliferation and chemotherapy resistance of colorectal cancer.
    Cancer Lett. 2022;534:215617.
    >> Share

    February 2022
  61. JIANG X, Wang C, Ke Z, Duo L, et al
    The ion channel TRPV1 gain-of-function reprograms the immune microenvironment to facilitate colorectal tumorigenesis.
    Cancer Lett. 2022;527:95-106.
    >> Share

  62. DINAMI R, Petti E, Porru M, Rizzo A, et al
    TRF2 cooperates with CTCF for controlling the oncomiR-193b-3p in colorectal cancer.
    Cancer Lett. 2022 Feb 28:215607. doi: 10.1016/j.canlet.2022.215607.
    >> Share

  63. YANG J, Guo W, Lu M
    Letter to the editor regarding"Radiosensitivity of colorectal cancer and radiation-induced gut damages are regulated by gasdermin E''.
    Cancer Lett. 2022 Feb 11. pii: S0304-3835(22)00038.
    >> Share

  64. FENG S, Huang Q, Deng J, Jia W, et al
    DAB2IP suppresses tumor malignancy by inhibiting GRP75-driven p53 ubiquitination in colon cancer.
    Cancer Lett. 2022;532:215588.
    >> Share

  65. AN Y, Xu B, Yan G, Wang N, et al
    YAP derived circ-LECRC functions as a "brake signal" to suppress hyperactivation of oncogenic YAP signalling in colorectal cancer.
    Cancer Lett. 2022 Feb 4:215589. doi: 10.1016/j.canlet.2022.215589.
    >> Share

  66. KE CH, Wang YS, Chiang HC, Wu HY, et al
    Xenograft cancer vaccines prepared from immunodeficient mice increase tumor antigen diversity and host T cell efficiency against colorectal cancers.
    Cancer Lett. 2022;526:66-75.
    >> Share

    January 2022
  67. GONG K, Hong Q, Wu H, Wang F, et al
    Gap junctions mediate glucose transfer to promote colon cancer growth in three-dimensional spheroid culture.
    Cancer Lett. 2022 Jan 27. pii: S0304-3835(22)00039.
    >> Share

  68. PAN G, Zhang K, Geng S, Lan C, et al
    PHF14 knockdown causes apoptosis by inducing DNA damage and impairing the activity of the damage response complex in colorectal cancer.
    Cancer Lett. 2022 Jan 21. pii: S0304-3835(22)00002.
    >> Share

  69. WANG H, Shao Q, Wang J, Zhao L, et al
    Decreased CXCR2 expression on circulating monocytes of colorectal cancer impairs recruitment and induces Re-education of tumor-associated macrophages.
    Cancer Lett. 2022;529:112-125.
    >> Share

  70. HUANG M, Liu M, Huang D, Ma Y, et al
    Tumor perivascular cell-derived extracellular vesicles promote angiogenesis via the Gas6/Axl pathway.
    Cancer Lett. 2022;524:131-143.
    >> Share

    December 2021
  71. TAN G, Lin C, Huang C, Chen B, et al
    Radiosensitivity of colorectal cancer and radiation-induced gut damages are regulated by gasdermin E.
    Cancer Lett. 2021;529:1-10.
    >> Share

  72. SHAO X, Sun S, Zhou Y, Wang H, et al
    Bacteroides fragilis restricts colitis-associated cancer via negative regulation of the NLRP3 axis.
    Cancer Lett. 2021;523:170-181.
    >> Share

  73. ZHONG F, Lin Y, Jing X, Ye Y, et al
    Innate tumor killers in colorectal cancer.
    Cancer Lett. 2021;527:115-126.
    >> Share

  74. MA R, Liu Y, Che X, Li C, et al
    Nuclear PD-L1 promotes cell cycle progression of BRAF-mutated colorectal cancer by inhibiting THRAP3.
    Cancer Lett. 2021 Dec 16. pii: S0304-3835(21)00630.
    >> Share

    November 2021
  75. HOU H, Chen D, Zhang K, Zhang W, et al
    Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation?
    Cancer Lett. 2021 Nov 26. pii: S0304-3835(21)00600.
    >> Share

  76. WANG D, Wang X, Si M, Yang J, et al
    Corrigendum to "Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages" [Canc. Lett. 474 (2020) 36-52].
    Cancer Lett. 2021 Nov 13. pii: S0304-3835(21)00577.
    >> Share

  77. SCHURMANN L, Schumacher L, Roquette K, Brozovic A, et al
    Inhibition of the DSB repair protein RAD51 potentiates the cytotoxic efficacy of doxorubicin via promoting apoptosis-related death pathways.
    Cancer Lett. 2021;520:361-373.
    >> Share

  78. PIN F, Prideaux M, Huot JR, Essex AL, et al
    Non-bone metastatic cancers promote osteocyte-induced bone destruction.
    Cancer Lett. 2021;520:80-90.
    >> Share

    September 2021
  79. LI N, Lu B, Luo C, Cai J, et al
    Incidence, mortality, survival, risk factor and screening of colorectal cancer: A comparison among China, Europe, and northern America.
    Cancer Lett. 2021;522:255-268.
    >> Share

  80. YIN Y, Jiang Z, Fu J, Li Y, et al
    Choline-induced SLC5A7 impairs colorectal cancer growth by stabilizing p53 protein.
    Cancer Lett. 2021 Sep 22. pii: S0304-3835(21)00481.
    >> Share

  81. BAI D, Sun T, Zhao J, Du J, et al
    Oroxylin A maintains the colonic mucus barrier to reduce disease susceptibility by reconstituting a dietary fiber-deprived gut microbiota.
    Cancer Lett. 2021;515:73-85.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016